
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
Keywords: Allergy; asthma; grass pollen; immunotherapy; sublingual; rhinoconjunctivitis; double-blind; placebo-controlled; Phleum pratense; pediatric; AE; Adverse event; IMP; Investigational medicinal product; SAE; Serious adverse event; SCIT; Subcutaneously admini